{
  "ptid_time": "070_S_4856_2012-07-25",
  "img_path": "/data/qiuhui/data/adni/images/070_S_4856/2012-07-25/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 76,774 mm³, 243.7% above the reference mean. With a Z-score of 6.10 (100.0th percentile), this represents profound enlargement; hippocampal volume measures 8,339 mm³, 8.5% above the reference mean. With a Z-score of 0.96 (83.0th percentile), this represents normal volume ; whole brain volume measures 1,038,320 mm³, 0.9% above the reference mean. With a Z-score of 0.11 (54.4th percentile), this represents normal volume ; entorhinal cortex volume measures 4,272 mm³, 9.7% above the reference mean. With a Z-score of 0.75 (77.5th percentile), this represents normal volume ; fusiform gyrus volume measures 17,192 mm³, 5.6% below the reference mean. With a Z-score of -0.63 (26.4th percentile), this represents normal volume ; middle temporal gyrus volume measures 20,221 mm³, 1.5% below the reference mean. With a Z-score of -0.13 (44.9th percentile), this represents normal volume . ",
  "text_data": "Age is 65.0 years. Gender is Female. Education: 18 years. Handedness: Right. Race: White. Medical history: Cardiovascular; Dermatologic-Connective Tissue; Endocrine-Metabolic. MMSE: 30.0. MoCA: 28.0. Logical Memory: 15.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 0.93 SUVR (mild reduced); Amyloid beta: 975.80 pg/mL (normal ); Total tau: 119.70 pg/mL (moderate reduced); Phosphorylated tau: 10.01 pg/mL (moderate reduced). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "Reasoning: The data shows profound ventricular enlargement (Z-score 6.10), which is a strong indicator of neurodegeneration, but hippocampal, whole brain, and other regional volumes are within normal ranges. Cognitive scores (MMSE 30, MoCA 28) are intact, and biomarkers (Aβ normal, reduced tau) do not suggest Alzheimer's pathology.  \nDiagnosis: CN (Cognitively Normal)  \nConfidence: Medium  \n\n(Confidence is medium because while ventricular enlargement is severe, the lack of cognitive impairment and normal AD biomarkers suggest this may represent an atypical or non-AD neurodegenerative process rather than active dementia. Further clinical correlation is needed.)",
  "timestamp": "2025-07-26T09:04:36.552335"
}